History of Migraine and Risk of COVID-19: A Cohort Study

Caronna, 2021, Headache as a symptom of COVID-19: narrative review of 1-year research, Curr Pain Headache Rep, 25, 73, 10.1007/s11916-021-00987-8 Gelaye, 2017, Body composition status and the risk of migraine: a meta-analysis, Neurology, 88, 1795, 10.1212/WNL.0000000000003919 Mahmoud, 2018, Migraine and the risk of cardiovascular and cerebrovascular events: a meta-analysis of 16 cohort studies including 1 152 407 subjects, BMJ Open, 8, 10.1136/bmjopen-2017-020498 Schurks, 2009, Migraine and cardiovascular disease: systematic review and meta-analysis, BMJ, 339, b3914, 10.1136/bmj.b3914 Fernandez-de-Las-Peñas, 2021, Previous history of migraine is associated with fatigue, but not headache, as long-term post-COVID symptom after severe acute respiratory SARS-CoV-2 infection: a case-control study, Front Hum Neurosci, 15, 10.3389/fnhum.2021.678472 Shapiro RE, Gallardo VJ, Caronna E, Pozo-Rosich P. The impact of headache disorders on COVID-19 survival: a world population-based analysis (preprint). medRxiv. 2021. Available at: https://www.medrxiv.org/content/10.1101/2021.03.10.21253280v1. Accessed May 1, 2023. Shapiro RE, Constantino H, Pozo-Rosich P, Martin A Migraine is associated with higher incidence of COVID-19, and higher frequency of COVID-19 symptoms, but lower COVID-19—Associated health care resource utilization rates. 63rd Annual Scientific Meeting American Headache Society. 2021. Available at: https://headachejournal.onlinelibrary.wiley.com/doi/full/10.1111/head.14130. Accessed May 1, 2023 Bolay, 2020, Are migraine patients at increased risk for symptomatic coronavirus disease 2019 due to shared comorbidities?, Headache, 60, 2508, 10.1111/head.13998 Ridker, 2005, A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women, N Engl J Med, 352, 1293, 10.1056/NEJMoa050613 Rexrode, 2000, Baseline characteristics of participants in the Women's Health Study, J Womens Health Gend Based Med, 9, 19, 10.1089/152460900318911 Centers for Disease Control and Prevention (CDC). Underlying medical conditions associated with higher risk for severe COVID-19: information for healthcare professionals. Available at:https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/underlyingconditions.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fscience%2Fscience-briefs%2Funderlying-evidence-table.html. Accessed May 1, 2023.